THRD THIRD HARMONIC BIO INC
120
$13.99
$0.02
(0.14%)
| Watchers | 120 |
| 52-Wk Low | $4.51 |
| 52-Wk High | $16.94 |
| Market Cap | $572.88M |
| Volume | 96,451.00 |
| 52-Wk High | $16.94 |
| 52-Wk Low | $4.51 |
The volume for Third Harmonic Bio stock increased for one day, resulting in a record-breaking daily growth of 204% of the 65-Day Volume Moving AverageTickeron - Stocks • about 2 months ago
THRD's total volume now sits at 229.4K. The +-0.21% price change was insignificant, leaving IBM's price at $9.44...
Share to Feed
SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases...
Third Harmonic Bio, Inc. (THRD) has issued an update. Geoff McDonough has been appointed as a Class III director at Third Harmonic Bio, Inc., follo...
THRD's Fiscal Discipline Leads to Lower Annual Net Loss Despite Zero RevenueRelated Stocks: THRD...
U.S. IND filed for THB335 with anticipated clinical trial start during 2Q'24 Strong financial position with cash and cash equivalents totaling $269.1 million as of December 31, 2023 SAN...
Third Harmonic Bio GAAP EPS of -$2.45 misses by $1.20...
LifeSci Capital analyst Sam Slutsky has maintained their bullish stance on THRD stock, giving a Buy rating today. Sam Slutsky has given his Buy rat...
In a report released today, Joseph Thome from TD Cowen maintained a Buy rating on Third Harmonic Bio, Inc. (THRD Research Report). The company's...
THRD's total volume now sits at 574.6K. The +2.46% price change was insignificant, leaving IBM's price at $9.99...